<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 5 Issue 1</issue_number>
<issue_period>2014 (January - March)</issue_period>
<title>SYNTHESIS AND STUDY OF ANTITUBERCULAR ACTIVITY OF PLUMBAGIN ANALOGS </title>
<abstract>Tuberculosis has been a serious public health problem for a long time. With the advent of anti-tubercular antibiotics in the late 1940s, the battle against tuberculosis seemed to have been won but the multi-drug resistance; re-infection and latent infection have become the major cause of concern for the treatment of tuberculosis all over the world. In the present study derivatives of Plumbagin, obtained from  lessThan i greaterThan Plumbago zeylanica  lessThan /i greaterThan (Family- lessThan i greaterThan Plumbaginaceae lessThan /i greaterThan ) have been synthesized. Out of the various analogs synthesized, the antitubercular activity of compound 1,2 and 3 was evaluated using standard H lessThan sub greaterThan 37 lessThan /sub greaterThan Rv and S,H,R and E sensitive  lessThan i greaterThan M. tuberculosis lessThan /i greaterThan  strains using LRF assay method. Compound 1 showed strongest activity against both standard H lessThan sub greaterThan 37 lessThan /sub greaterThan Rv and S,H,R and E sensitive  lessThan i greaterThan M. tuberculosis lessThan /i greaterThan  strains as compared to standard Rifampicin. The other compounds are proved to be more active against standard H lessThan sub greaterThan 37 lessThan /sub greaterThan Rv and S,H,R and E sensitive  lessThan i greaterThan M.tuberculosis lessThan /i greaterThan  strain as compared to Rifampicin.</abstract>
<authors>NISHI NAYAK , MEENAKSHI BAJPAI  AND  BALKISHEN RAZDAN</authors>
<keywords>Plumbagin, Streptomycin(S), Isoniazid(H), Rifampicin(R),Ethambutol(R)</keywords>
<pages>388-395</pages>
</article>
</Journal>
